Article
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
PloS one - 25 Jun 2008
Madsen Bo Eskerod, Ramos Eliana Marisa, Boulard Mathieu, Duda Katarzyna, Overgaard Jens, Nordsmark Marianne, Wiuf Carsten, Hansen Lise Lotte
Abstract excerpt
UNLABELLED: THE BACKGROUND: Ribonuclease L (RNASEL), encoding the 2'-5'-oligoadenylate (2-5A)-dependent RNase L, is a key enzyme in the interferon induced antiviral and anti-proliferate pathway. Mutations in RNASEL segregate with the disease in prostate cancer families and specific genotypes are associated with an increased risk of prostate cancer. Infection by human papillomavirus (HPV) is the major risk factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
